Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Conducting clinical trials-costs, impacts, and the value of clinical trials networks: A scoping review.

Bentley C, Cressman S, van der Hoek K, Arts K, Dancey J, Peacock S.

Clin Trials. 2019 Apr;16(2):183-193. doi: 10.1177/1740774518820060. Epub 2019 Jan 10.

PMID:
30628466
2.

Viperin is an important host restriction factor in control of Zika virus infection.

Van der Hoek KH, Eyre NS, Shue B, Khantisitthiporn O, Glab-Ampi K, Carr JM, Gartner MJ, Jolly LA, Thomas PQ, Adikusuma F, Jankovic-Karasoulos T, Roberts CT, Helbig KJ, Beard MR.

Sci Rep. 2017 Jun 30;7(1):4475. doi: 10.1038/s41598-017-04138-1.

3.

HCV RNA traffic and association with NS5A in living cells.

Fiches GN, Eyre NS, Aloia AL, Van Der Hoek K, Betz-Stablein B, Luciani F, Chopra A, Beard MR.

Virology. 2016 Jun;493:60-74. doi: 10.1016/j.virol.2016.02.016. Epub 2016 Mar 19.

4.

Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis.

Cromwell I, Ferreira Z, Smith L, van der Hoek K, Ogilvie G, Coldman A, Peacock SJ.

Curr Oncol. 2016 Feb;23(Suppl 1):S14-22. doi: 10.3747/co.23.2914. Epub 2016 Feb 29.

5.

Symptom Clusters in Advanced Cancer Patients: An Empirical Comparison of Statistical Methods and the Impact on Quality of Life.

Dong ST, Costa DS, Butow PN, Lovell MR, Agar M, Velikova G, Teckle P, Tong A, Tebbutt NC, Clarke SJ, van der Hoek K, King MT, Fayers PM.

J Pain Symptom Manage. 2016 Jan;51(1):88-98. doi: 10.1016/j.jpainsymman.2015.07.013. Epub 2015 Aug 21.

6.

Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.

Regier DA, Peacock SJ, Pataky R, van der Hoek K, Jarvik GP, Hoch J, Veenstra D.

CMAJ. 2015 Apr 7;187(6):E190-E197. doi: 10.1503/cmaj.140697. Epub 2015 Mar 9.

7.

Fatty Acids Induce a Pro-Inflammatory Gene Expression Profile in Huh-7 Cells That Attenuates the Anti-HCV Action of Interferon.

Tse E, Helbig KJ, Van der Hoek K, McCartney EM, Van der Hoek M, George J, Beard MR.

J Interferon Cytokine Res. 2015 May;35(5):392-400. doi: 10.1089/jir.2014.0165. Epub 2015 Jan 14.

PMID:
25588104
8.

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.

Teckle P, McTaggart-Cowan H, Van der Hoek K, Chia S, Melosky B, Gelmon K, Peacock S.

Health Qual Life Outcomes. 2013 Dec 1;11:203. doi: 10.1186/1477-7525-11-203.

9.

Exploring colposcopists' attitudes towards use of HPV testing as a primary screening tool for cervical cancer in British Columbia.

Regier DA, van der Hoek K, Ogilvie G, Smith L, Henwood E, Miller DM, McTaggart-Cowan H, Peacock SJ.

J Obstet Gynaecol Can. 2013 Jul;35(7):657-63.

PMID:
23876645
10.

Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.

Phillips RJ, Helbig KJ, Van der Hoek KH, Seth D, Beard MR.

World J Gastroenterol. 2012 Jul 14;18(26):3389-99. doi: 10.3748/wjg.v18.i26.3389.

11.

Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: a real-world cost-effectiveness analysis.

Cromwell I, van der Hoek K, Malfair Taylor SC, Melosky B, Peacock S.

Lung Cancer. 2012 Jun;76(3):472-7. doi: 10.1016/j.lungcan.2011.12.003. Epub 2012 Jan 9.

PMID:
22226627
12.

The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities.

Teckle P, Peacock S, McTaggart-Cowan H, van der Hoek K, Chia S, Melosky B, Gelmon K.

Health Qual Life Outcomes. 2011 Nov 28;9:106. doi: 10.1186/1477-7525-9-106.

13.

Erlotinib or docetaxel for second-line treatment of non-small cell lung cancer: a real-world cost-effectiveness analysis.

Cromwell I, van der Hoek K, Melosky B, Peacock S.

J Thorac Oncol. 2011 Dec;6(12):2097-103. doi: 10.1097/JTO.0b013e31822f657a.

14.

Exploring global changes in nitrogen and phosphorus cycles in agriculture induced by livestock production over the 1900-2050 period.

Bouwman L, Goldewijk KK, Van Der Hoek KW, Beusen AH, Van Vuuren DP, Willems J, Rufino MC, Stehfest E.

Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):20882-7. doi: 10.1073/pnas.1012878108. Epub 2011 May 16. Erratum in: Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):21195.

15.

MicroRNA-regulated pathways associated with endometriosis.

Ohlsson Teague EM, Van der Hoek KH, Van der Hoek MB, Perry N, Wagaarachchi P, Robertson SA, Print CG, Hull LM.

Mol Endocrinol. 2009 Feb;23(2):265-75. doi: 10.1210/me.2008-0387. Epub 2008 Dec 12.

16.

Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome.

Wu R, Fujii S, Ryan NK, Van der Hoek KH, Jasper MJ, Sini I, Robertson SA, Robker RL, Norman RJ.

Hum Reprod. 2007 Feb;22(2):527-35. Epub 2006 Sep 22.

PMID:
16997933
17.

Surface N balances and reactive N loss to the environment from global intensive agricultural production systems for the period 1970-2030.

Bouwman AF, Van Drecht G, van der Hoek KW.

Sci China C Life Sci. 2005 Dec;48 Spec No:767-79.

PMID:
16512200
18.

Troglitazone regulates peroxisome proliferator-activated receptors and inducible nitric oxide synthase in murine ovarian macrophages.

Minge CE, Ryan NK, Van Der Hoek KH, Robker RL, Norman RJ.

Biol Reprod. 2006 Jan;74(1):153-60. Epub 2005 Sep 28.

PMID:
16192401
19.

Surface N balances and reactive N loss to the environment from global intensive agricultural production systems for the period 1970-2030.

Bouwman AF, Van Drecht G, van der Hoek KW.

Sci China C Life Sci. 2005 Sep;48 Suppl 2:767-79. doi: 10.1007/BF03187117.

PMID:
20549433
20.

Macrophage contributions to ovarian function.

Wu R, Van der Hoek KH, Ryan NK, Norman RJ, Robker RL.

Hum Reprod Update. 2004 Mar-Apr;10(2):119-33. Review.

PMID:
15073142
21.

Leptin and leptin receptor expression in the rat ovary.

Ryan NK, Van der Hoek KH, Robertson SA, Norman RJ.

Endocrinology. 2003 Nov;144(11):5006-13. Epub 2003 Aug 14.

PMID:
12959975
22.

Nitrogen efficiency in agriculture in Europe and India.

Van der Hoek KW.

ScientificWorldJournal. 2001 Nov 27;1 Suppl 2:148-54.

24.

Expression of leptin and its receptor in the murine ovary: possible role in the regulation of oocyte maturation.

Ryan NK, Woodhouse CM, Van der Hoek KH, Gilchrist RB, Armstrong DT, Norman RJ.

Biol Reprod. 2002 May;66(5):1548-54.

PMID:
11967222
25.

The in vivo and in vitro effects of exogenous leptin on ovulation in the rat.

Duggal PS, Van Der Hoek KH, Milner CR, Ryan NK, Armstrong DT, Magoffin DA, Norman RJ.

Endocrinology. 2000 Jun;141(6):1971-6.

PMID:
10830279
26.

Intrabursal injection of clodronate liposomes causes macrophage depletion and inhibits ovulation in the mouse ovary.

Van der Hoek KH, Maddocks S, Woodhouse CM, van Rooijen N, Robertson SA, Norman RJ.

Biol Reprod. 2000 Apr;62(4):1059-66.

PMID:
10727278
27.

Characterization of ovarian function in granulocyte-macrophage colony-stimulating factor-deficient mice.

Jasper MJ, Robertson SA, Van der Hoek KH, Bonello N, Brännström M, Norman RJ.

Biol Reprod. 2000 Mar;62(3):704-13.

PMID:
10684813
28.

Effects of interleukin (IL)-6 on luteinizing hormone- and IL-1beta-induced ovulation and steroidogenesis in the rat ovary.

Van der Hoek KH, Woodhouse CM, Brännström M, Norman RJ.

Biol Reprod. 1998 May;58(5):1266-71.

PMID:
9603262

Supplemental Content

Loading ...
Support Center